BOSTON
Boston Red Sox TV analyst Jerry Remy said Monday he has been diagnosed with lung cancer for a fifth time and will have surgery to treat it in two weeks.
The 64-year-old Remy spoke to reporters before working the opener of Boston’s two-game series against the Philadelphia Phillies.
“It’s obviously disappointing to me, but it’s something that I’ve been through a number of times,” he said. “It has not spread. It’s located in one spot and surgery will remove it. They’ll be a recovery time after surgery.”
Remy plans to work up until the surgery and expects to return after the All-Star break.
The former Red Sox second baseman known on broadcasts as “RemDawg” said the cancer was detected during his regular three-month exam.
“I was not one to go see doctors,” he said. “If you don’t go to your doctor, you don’t have much of a chance to find out.”
Remy played for Boston from 1978-84 and is a member of the team’s Hall of Fame. He has been a popular Red Sox television analyst since 1988.
Remy was originally diagnosed with cancer in 2008. He said baseball has kept him busy as he’s gone through treatments each time, and that each brings a new challenge.
“I’ve had cancer five times. Enough is enough,” he said. “The fact is other people can avoid it, it’s not fun. It wears you down. I’m not going to lie, it wears you down.
“There’s a lot of people a lot worse than me, so I consider myself lucky at the stage that I’m at.”
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less